52 North Health
52 North Health is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 2 tracked investors.
About 52 North Health
52 North Health is a startup founded in 2020 based in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
52 North Health develops affordable, patient-centered medical technology solutions for cancer patients, primarily focusing on the NeutroCheck device, which uses a finger-prick blood test and AI to monitor risk of neutropenic sepsis in patients undergoing chemotherapy, enabling at-home monitoring and improving health outcomes and equity.
Explore 52 North Health's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.